In the complete series of 735 CRC 89 (12.1%) were classified as MSI, and 432 were analyzed for single base substitution (SNS) mutations in KRAS and 392 for SNS mutations in TP53. A subset of 261 cases was also analyzed for MGMT methylation. This evidence concerns the gene TP53 and colorectal carcinoma.